LEPROSY TREATMENT MARKET ANALYSIS

Market News

Key Developments

1. Key players in the market are focused on various business strategies such as gaining product approval from regulatory authorizes, in order to expand product portfolio and gain competitive edge in the market. For instance, in February 2019, Novartis International AG received U.S. Food and Drug Administration approval for ‘Egaten’, a drug used for fascioliasis and tropical diseases, which include leprosy.
2. Major players in the market are involved in different business strategies such as collaboration and partnership, in order to develop novel products. For instance, in March 2019, The Novartis Foundation, a non-profit organization and part of Novartis International AG, entered into partnership with Microsoft to develop artificial intelligence (AI)-enabled digital health tool and a leprosy intelligent image atlas to boost the early detection of leprosy.
3. Key companies in the market are focused on various business strategies such as partnership and collaboration, in order to provide better solution for leprosy treatment. For instance, in September 2018, HDT Biotech Corporation collaborated with Infectious Disease Research Institute (IDRI) to develop cost-effective test with enhanced sensitivity for detecting infection with M. leprae, which causes leprosy.